Product

Cytarabine + Daunorubicin Liposome

Aliases

(cytarabine: daunorubicin) liposome for injection

1 clinical trial

1 indication

Indication

Acute Myeloid Leukemia

Clinical trial

A Randomized, Open-label, Two-period, Two-way Crossover Bioequivalence Study of Two (Cytarabine: Daunorubicin) Liposome for Injection in Elderly AML Subjects

Status: Recruiting, Estimated PCD: 2025-04-01